This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:


peer-reviewed publication

trusted source


More evidence suggests regular consumption of melatonin can reduce chances of age-related macular degeneration

More evidence suggests regular consumption of melatonin can reduce chances of age-related macular degeneration
Picture of the back of the eye showing intermediate age-related macular degeneration. Credit: National Eye Institute

A team of medical researchers from Case Western Reserve University School of Medicine and the Cleveland Clinic's Center for Ophthalmic Bioinformatics has found further evidence that regular consumption of melatonin reduces an older person's chances of developing age-related macular degeneration (AMD), a disease that often leads to blindness.

In their study, published in the journal JAMA Ophthalmology, the group researched case histories of 200,000 looking for an association between regular consumption of melatonin and the development of AMD.

Prior research has shown that as they age, many people begin to experience degeneration of the macula, a central part of the retina. Currently, approximately 11 million people in the U.S. alone are experiencing due to AMD. Medical scientists have been looking for ways to prevent or stop the progression of the disease for many years. Some progress has been made, but there is still no cure.

In recent years, research teams have been finding that people taking melatonin supplements may be less likely to develop the condition. In 2020, one team found that the higher levels of melatonin can prevent retinal damage due to AMD.

The following year, another team found that patients with AMD tended to have lower-than-average amounts of melatonin in their blood and tears. In this new effort, the research team looked at the of 200,000 older people covering the years 2008 to 2023 looking for an association.

They found that out of 121,523 patients aged 50 years or older who had no evidence of AMD, many were regular users of melatonin supplements. They also found that many patients who began taking after developing AMD experienced slower degradation than patients who did not begin to take the supplements.

Melatonin is a hormone that is produced naturally in the brain; it has been strongly associated with the sleep cycle. The brain makes more of it in response to darkness. Because of that, several companies make and sell melatonin as a dietary supplement intended to help people having trouble going to sleep.

This new study adds more evidence that regular consumption of could ward off the development and progression of AMD.

More information: Hejin Jeong et al, Melatonin and Risk of Age-Related Macular Degeneration, JAMA Ophthalmology (2024). DOI: 10.1001/jamaophthalmol.2024.1822

Journal information: JAMA Ophthalmology

© 2024 Science X Network

Citation: More evidence suggests regular consumption of melatonin can reduce chances of age-related macular degeneration (2024, June 7) retrieved 21 June 2024 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Video: What are the benefits, risks of sleeping with melatonin gummies?


Feedback to editors